LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.77 84.90 1 411 0.0024 -0.8579
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.77 84.90 808 411 1.9648 1.6909
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 1 447 0.0022 -0.8431
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 909 447 2.0316 1.6879
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 1 447 0.0022 -0.8431
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 905 447 2.0227 1.6829
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 2 447 0.0045 -0.7905
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 806 447 1.8014 1.5564
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 1 447 0.0022 -0.8431
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
9.47 84.90 849 447 1.8975 1.6124
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 5 492 0.0102 -0.6727
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 975 492 1.9803 1.6184
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 1 492 0.0020 -0.8265
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 1008 492 2.0473 1.6530
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 4 492 0.0081 -0.7002
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 874 492 1.7751 1.5079
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 1 492 0.0020 -0.8265
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
11.18 84.90 891 492 1.8097 1.5270
MN20160318_Q02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 41 531 0.0772 -0.2406
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 1050 531 1.9774 1.5881
MN20160318_Q02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 3 531 0.0056 -0.7174
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 1072 531 2.0188 1.6085
MN20160318_Q02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 4 531 0.0075 -0.6850
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 919 531 1.7307 1.4609
MN20160318_Q02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
12.88 84.90 2 531 0.0038 -0.7576
MN20160318_Q02
H15